Journal article icon

Journal article

Annonacin exerts antitumor activity through induction of apoptosis and extracellular signal-regulated kinase inhibition

Abstract:

Background: Endometrial cancer (EC) is the most common gynecologic malignancy in developed countries. Annonacin, a natural pure compound extracted from the seeds of Annona muricata, is a potential alternative therapeutic agent to treat EC. 

Objective: To study the antitumor activity of annonacin and its mechanism of action in EC cells (ECCs). 

Materials and Methods: Viability of ECCs treated with annonacin for 72 h was determined using methyl thiazolyl tetrazolium assay. The induction of cell cycle arrest and apoptotic cell death was evaluated using propidium iodide and annexin V-PE/7-AAD assay, respectively. DNA strand breaks were visualized using transferase dUTP nick end labeling assay, and the effects of annonacin on survival signaling were determined using western blotting. 

Results: Annonacin exhibited antiproliferative effects on EC cell lines (ECC-1 and HEC-1A) and primary cells (EC6-ept and EC14-ept) with EC50values ranging from 4.62 to 4.92 μg/ml. EC cells were shown arrested at G2/M phase after treated with 4 μg/ml of annonacin for 72 h. This led to a significant increase in apoptotic cell death (65.7%) in these cells when compared to vehicle-treated cells (P < 0.005). We further showed that annonacin-mediated apoptotic cell death was associated with an increase in caspase-3 cleavage and DNA fragmentation. Cell apoptosis was accompanied with downregulation of extracellular signal-regulated kinase survival protein expression and induction of G2/M cell cycle arrest. 

Conclusion: Annonacin may be a potential novel therapeutic agent for EC patients.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.4103/pr.pr_19_17

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Women's and Reproductive Health
Role:
Author


More from this funder
Grant:
Research Grant (RP019b


Publisher:
Medknow Publications
Journal:
Pharmacognosy Research More from this journal
Volume:
9
Issue:
4
Pages:
378-383
Publication date:
2017-11-16
Acceptance date:
2017-04-26
DOI:
ISSN:
0976-4836


Keywords:
Pubs id:
pubs:747112
UUID:
uuid:890377f3-1dc6-4a7e-8e1e-f9225007659a
Local pid:
pubs:747112
Source identifiers:
747112
Deposit date:
2017-11-21
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP